Abstract:Background: The microbiota-gut-lung axis has elucidated a potential association between gut microbiota and idiopathic pulmonary fibrosis (IPF). However, there is a paucity of population-level studies with providing robust evidence for establishing causality. This two-sample Mendelian randomization (MR) analysis aimed to investigate the causal relationship between the gut microbiota and IPF as well as lung function. Materials and methods: Adhering to Mendel's principle of inheritance, this MR analysis utilized summary-level data from respective genome-wide association studies (GWAS) involving 211 gut microbial taxa, IPF, and lung function indicators such as FEV 1 , FVC, and FEV 1 /FVC. A bidirectional two-sample MR design was employed, utilizing multiple MR analysis methods, including inverse variance-weighted (IVW), weighted median, MR-Egger, and weighted mode. Multivariable MR (MVMR) was used to uncover mediating factors connecting the exposure and outcome. Additionally, comprehensive sensitivity analyses were conducted to ensure the robustness of the results. Results: The MR results confirmed four taxa were found causally associated with the risk of IPF. Order Bifidobacteriales (OR=0.773, 95% CI: 0.610–0.979, p=0.033), Family Bifidobacteriaceae (OR=0.773, 95% CI: 0.610–0.979, p=0.033), and Genus RuminococcaceaeUCG009 (OR=0.793, 95% CI: 0.652–0.965, p=0.020) exerted protective effects on IPF, while Genus Coprococcus2 (OR=1.349, 95% CI: 1.021–1.783, p=0.035) promote the development of IPF. Several taxa were causally associated with lung function, with those in Class Deltaproteobacteria, Order Desulfovibrionales, Family Desulfovibrionaceae, Class Verrucomicrobiae , Order Verrucomicrobiales and Family Verrucomicrobiaceae being the most prominent beneficial microbiota, while those in Family Lachnospiraceae, Genus Oscillospira , and Genus Parasutterella were associated with impaired lung function. As for the reverse analysis, MR results confirmed the effects of FEV 1 and FVC on the increased abundance of six taxa ( Phylum Actinobacteria, Class Actinobacteria, Order Bifidobacteriales, Family Bifidobacteriaceae, Genus Bifidobacterium , and Genus Ruminiclostridium9 ) with a boosted level of evidence. MVMR suggested monounsaturated fatty acids, total fatty acids, saturated fatty acids, and ratio of omega-6 fatty acids to total fatty acids as potential mediating factors in the genetic association between gut microbiota and IPF. Conclusion: The current study suggested the casual effects of the specific gut microbes on the risk of IPF and lung function. In turn, lung function also exerted a positive role in some gut microbes. A reasonable dietary intake of lipid substances has a certain protective effect against the occurrence and progression of IPF. This study provides novel insights into the potential role of gut microbiota in IPF and indicates a possible gut microbiota-mediated mechanism for the prevention of IPF.

Changes in pharyngeal microbiota composition in patients with idiopathic pulmonary fibrosis

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis

Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension

High Throughput Sequencing Technology Reveals Alteration of Lower Respiratory Tract Microbiome in Severe Aspiration Pneumonia and Its Association with Inflammation.

Upper respiratory tract mycobiome alterations in different kinds of pulmonary disease

Buccal Microbiome and Survival in Idiopathic Pulmonary Fibrosis: CleanUP-IPF

High Bacterial Load Predicts Poor Outcomes in Patients with Idiopathic Pulmonary Fibrosis

Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease

Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study

Microbial profiles of peri-implant mucositis and peri-implantitis: Submucosal microbial dysbiosis correlates with disease severity

Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.

Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases

Airway Microbiota is Associated with the Severity of Non‐cf Bronchiectasis

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis

Oral Microbial Dysbiosis in Patients with Periodontitis and Chronic Obstructive Pulmonary Disease

The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation

Alterations in the gut microbiota of patients with silica-induced pulmonary fibrosis

Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study

The Interactions of Airway Bacterial and Fungal Communities in Clinically Stable Asthma